Mamady Hapsatou

Summary

As a molecular biologist, I obtained my PhD in 2006 at Carleton University studying gene expression in hibernating animals. Later on, I used state-of-the-art technology at Health Canada in the field of genomics and proteomics, investigating biomarkers of exposure to toxicants. At CHEO RI, I study how genetic mutations causing rare diseases affect translation of mitochondrial proteins in patients’ fibroblast cells with the long-term goal of finding new therapeutic approaches of disease treatment.

Cell Biology Genomics Molecular Biology Toxicology